The in vitro stability and plasma pharmacokinetics of 5, 10-methylenet
etrahydrofolic acid (CH2FH4), trtmhydrofolic acid (FH4), 5-methyltetra
hydrofolic acid (CH3FH4), and 5-formyltetrahydrofolic acid (5-CHOFH4)
were studied in view of their-potential usefulness in cancer chemother
apy. Analysis of reduced folates was done on a high performance liquid
chromatography (HPLC) system. The high sensitivity of FH4 and CH2FH4
to oxidation call be circumvented by use of high concentrations of the
folates, addition of ascorbate, and by thorough exclusion of atmosphe
ric O-2. Intravenous injection of 200 mg FH4 or CH2FH4 resulted in ave
rage peak concentrations Of 69.2 +/- 3.2 nmol/ml and 46.3 +/- 2.6 nmol
/ml, respectively. The plasma concentration curves support the concept
that these highly oxygen-sensitive reduced folates can be reliably ad
ministered as pharmaceuticals to cancer patients through the use of a
suitable air-occlusive system for their preparation and administration
.